Update on Regulatory Review of Aducanumab in the European Union
Go back to Update on Regulatory Review of Aducanumab in the European Union| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.97 -0.68 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.65 | 52 Week High | $333.65 | |||
| Open | $218.11 | 52 Week Low | $223.02 | |||
| Day High | $219.30 | P/E | 27.65 | |||
| Day Low | $215.37 | EPS | $7.81 | |||
| Volume | 234,941 | |||||
